ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 110 filers reported holding ENZO BIOCHEM INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $422,000 | +97.2% | 50,400 | +63.1% | 0.57% | +57.2% |
Q4 2016 | $214,000 | +52.9% | 30,900 | -30.2% | 0.36% | +2916.7% |
Q3 2015 | $140,000 | -51.9% | 44,300 | -54.0% | 0.01% | -50.0% |
Q2 2015 | $291,000 | +14.6% | 96,200 | +11.9% | 0.02% | +9.1% |
Q1 2015 | $254,000 | +156.6% | 86,000 | +285.7% | 0.02% | +144.4% |
Q4 2014 | $99,000 | -35.3% | 22,300 | -25.2% | 0.01% | -35.7% |
Q3 2014 | $153,000 | – | 29,800 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARBERT FUND ADVISORS, INC. | 5,620,681 | $20,234,000 | 30.10% |
Evermore Global Advisors, LLC | 4,007,851 | $14,428,000 | 3.48% |
Fondren Management LP | 355,000 | $1,278,000 | 1.06% |
CORRADO ADVISORS, LLC | 196,309 | $707,000 | 0.64% |
MARATHON CAPITAL MANAGEMENT | 193,580 | $697,000 | 0.28% |
KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $344,000 | 0.23% |
EAM Investors, LLC | 203,962 | $734,000 | 0.19% |
Ariel Investments | 1,026,313 | $3,695,000 | 0.05% |
HighVista Strategies LLC | 19,500 | $70,000 | 0.05% |
Paradigm Financial Partners, LLC | 17,175 | $60,000 | 0.03% |